Objective: To probe into the efficacy and availability of budesonide combined with montelukast sodium and low-temperature plasma radiofrequency ablation in the treatment of pediatric snoring. Methods: Eighty-four children with pediatric snoring admitted into our hospital from Jan. 2017 to Jun. 2018 were enrolled to be divided into the control group and the observation group via the random number table

with 42 cases in each group. Both groups were treated with low-temperature plasma radiofrequency ablation under nasal endoscope. The control group was given anti-infective treatment of cefaclor for 7 d after surgery; on the basis of anti-infective treatment

the observation group was additionally given budesonide inhalation and montelukast sodium on the 2nd d after surgery. Clinical efficacy

surgery related indicators and ventilation function indicators of two groups were compared. Results: The effective rate of the observation group was 97.61%

compared with 90.48% of the control group

the difference was statistically significant (P<0.05). The recovery rate of the observation group was 61.90%

higher than 35.71% of the control group (P<0.05). The relief time of clinical symptoms

healing time of wound and length of stay in the observation group were shorter than those in the control group (P<0.05). The apnea hypopnea index (AHI) of the observation group was (8.45±5.63) times/hour

significantly lower than (19.67±6.29) times/hour of the control group (P<0.05). The lowest oxygen saturation(LSaO2) of the observation group was (91.76±6.65)%

higher than (79.50±8.17)% of the control group (P<0.05). Conclusion: Budesonide combined with montelukast sodium and low-temperature plasma radiofrequency ablation in the treatment of pediatric snoring can improve the ventilation function

increase the recovery rate

accelerate the relief of clinical symptoms

shorten the healing time of wound and length of stay

which is worthy of clinical promotion